Novartis
Novartis Reports Positive Data from COVID-19 Antiviral Drug Trial
Novartis will license a new drug it has been developing with Molecular Partners to treat COVID-19 after getting positive trial data, the companies ...Read More
Personalize Your Experience.
Get started customizing today!
Become a Member Already a NJBIA member? Sign In
Employment & Labor Law
Economic Development
Energy & Environmental Quality
Taxation & Economic Development
Government Affairs
Health Affairs
Law
Education & Workforce Development